Clinical Trial Update: Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients [NA]

View source ↗

Summary

Recruitment is ongoing for a study evaluating the effects of Vivatlac Synbiotic on gut microbiota in patients with Irritable Bowel Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Vivatlac Synbiotic

Snippet

Sponsor: The President Stanisław Wojciechowski State University of Applied Sciences in Kalisz | Conditions: Irritable Bowel Syndrome | NA | Status: RECRUITING